Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
about
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.Long-term home noninvasive mechanical ventilation increases systemic inflammatory response in chronic obstructive pulmonary disease: a prospective observational study.Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.Relationship between the GOLD combined COPD assessment staging system and bacterial isolationA persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.Trends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation.Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling.Update in chronic obstructive pulmonary disease 2007.Optimizing antibiotic selection in treating COPD exacerbationsDo we need new antibiotics for treating exacerbations of COPD?Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study.Antibiotics in acute exacerbations of chronic bronchitis.Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis.Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease.The Clinical Management Of Lower Respiratory Tract Infections.Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.The Most Common Detected Bacteria in Sputum of Patients with the Acute Exacerbation of COPD.Bacterial infection, airway and systemic inflammation and clinical outcomes before and after treatment of AECOPD, a longitudinal and cross-sectional study.Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?Do not do in COPD: consensus statement on overuse.Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.Purulent sputum predictive of bacterial infection in COPD
P2860
Q33711672-60322036-4411-4C4A-AADA-E7D8C0AFF68FQ33757660-7C8AEBBC-E922-4F5A-AB73-BA207B251AD5Q33905336-7F402450-BE42-432A-9805-E5004736F286Q34293156-DE763F08-7A02-4E5E-A1E3-527D36E63BECQ35049328-499C1326-B895-4A29-8B7C-2DF4945EEEFAQ35753636-912C306E-EECE-44C9-93A6-05380C284297Q36113688-7430C2A3-4F18-48A9-8036-88829F6BA3CBQ37029615-C5723733-0687-4EED-BBC9-780306531EC4Q37061898-9BCAD5E2-FC05-4B98-86D8-97271DE10F2FQ37129292-D869E0E9-A9FD-456A-9A3C-040E9C200E28Q37167347-019DA73C-04E4-4BA1-B98B-F47326571F7FQ37362577-D1171EF8-0E4B-4475-A903-5656F4CEE034Q37717451-A7DFB014-05B8-4483-8425-BA2731735C98Q37727171-6285F888-4417-48D4-A69E-BEE58F328577Q37814698-F49E70EE-2FEF-4117-B8CE-F9D7B6B6662CQ38056764-E5919118-5912-4982-954A-769D50F42B90Q38667550-0F515151-AB67-4012-BDA4-1C31AD747148Q39370816-CFCABED3-8E32-4615-8D7C-5815A326C93FQ40785029-CF3ACAA2-F0D1-44C7-8190-F4DCB040E002Q40789565-27192B70-DB71-40AF-9B65-A2E7C313C0F2Q41911651-37756B27-24E9-46D2-977F-DF28D92D25E3Q42220298-C0FE9D48-08E0-4C93-8408-F4DE28D96598Q43518845-7ED93004-1D8E-46C2-93EC-CE76886B2C87Q49625748-3BFB621B-3465-43B7-87C1-0CEF31F7EF88Q54110999-22D0BF56-E90A-4545-BC6B-C840EF81229FQ55400934-18E8B5DB-18F8-4F10-A501-E3692920107CQ56492158-061019E0-16C4-4900-825C-F8C152142A0F
P2860
Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@ast
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@en
type
label
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@ast
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@en
prefLabel
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@ast
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@en
P2093
P2860
P356
P1433
P1476
Bronchoscopic validation of th ...... obstructive pulmonary disease.
@en
P2093
Antoni Torres
Carlos Agustí
Joaquim Angrill
Jorge Puig De la Bellacasa
Néstor Soler
P2860
P356
10.1136/THX.2005.056374
P407
P577
2006-08-23T00:00:00Z